Australian Partnership (for) Preparedness Research On InfectiouS (disease) Emergencies (APPRISE)
Funder
National Health and Medical Research Council
Funding Amount
$4,996,416.00
Summary
We have assembled national experts in clinical, laboratory and public health research to ensure Australia is equipped for a coordinated, effective and evidence based response to infectious diseases. This multidisciplinary team will create and share new knowledge to detect, prevent and manage emerging infection threats. We will train a robust cross-sectoral work force and develop sustainable research capacity integrated within the health system to ensure national and regional health security.
A framework for adapting child interview protocols in complex cases. This project aims to develop–in collaboration with Aboriginal and other industry co-researchers–a ‘how to’ framework for effectively adapting standard child abuse interview protocols to accommodate the complexities that create barriers to disclosure. Complex cases necessitate interview adaption, but it requires systematic guidance and an interdisciplinary, practitioner-driven approach to be effective. This innovative framework ....A framework for adapting child interview protocols in complex cases. This project aims to develop–in collaboration with Aboriginal and other industry co-researchers–a ‘how to’ framework for effectively adapting standard child abuse interview protocols to accommodate the complexities that create barriers to disclosure. Complex cases necessitate interview adaption, but it requires systematic guidance and an interdisciplinary, practitioner-driven approach to be effective. This innovative framework is expected to have long-term benefits for services that support children’s well-being, through improvements in the quality of evidence underpinning decisions. By enhancing interviewer capability, there will also be fewer cases prematurely exiting the justice system before forensic interview or investigation.Read moreRead less
Impact Of DTP Schedules On The Immunogenicity Of 2 Doses Of 13v-PCV Followed By An Early Booster
Funder
National Health and Medical Research Council
Funding Amount
$2,651,687.00
Summary
This project aims to come up with a vaccination schedule to make pneumococcal vaccines more effective and affordable for Fiji and other developing countries. We will evaluate schedules involving a 2 dose primary series in early infancy with a booster at 9 months of age. We will compare the immune responses to 3 different primary series and 2 booster options. The results of this project will be used to provide advice, at global and country levels, regarding introduction of pneumococcal vaccines.